Clinical Responses in Patients with Inadequate Response to bDMARDs upon Treatment with Upadacitinib

被引：0
|
作者：
Weinblatt, Michael [1 ]
Thomson, Glen [2 ]
Chen, Kun [3 ]
Meerwein, Sebastian [4 ]
Schlacher, Casey [3 ]
Cush, John [5 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] CIADS Res, Winnipeg, MB, Canada
[3] AbbVie Inc, N Chicago, IL USA
[4] AbbVie GmbH Co KG, Ludwigshafen, Germany
[5] Baylor Univ, Med Ctr, Dallas, TX USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0515
引用
收藏
页数：3
相关论文
共 50 条
  • [31] IMPACT OF UPADACITINIB VERSUS ABATACEPT ON INDIVIDUAL DISEASE OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSES TO BIOLOGIC DMARDS
    Van Vollenhoven, R.
    Rubbert-Roth, A.
    Hall, S.
    Xavier, R.
    Shmagel, A.
    Song, Y.
    Anyanwu, S.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 626 - 626
  • [32] Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy
    Zeng, Xiaofeng
    Zhao, Dongbao
    Radominski, Sebastiao C.
    Keiserman, Mauro
    Lee, Chang K.
    Meerwein, Sebastian
    Enejosa, Jeffrey
    Sui, Yunxia
    Mohamed, Mohamed-Eslam F.
    Park, Won
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1530 - 1539
  • [33] EVALUATION OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST-GENERATION JANUS KINASE INHIBITORS
    Kamiya, M.
    Mori, S.
    Yamazaki, K.
    Togawa, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 608 - 608
  • [34] Impact of Upadacitinib Versus Abatacept on Individual Disease Outcomes in Patients With Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDs
    Van Vollenhoven, Ronald
    Rubbert-Roth, Andrea
    Hall, Stephen
    Xavier, Ricardo M.
    Shmagel, Anna
    Song, Yanna
    Anyanwu, Samuel I.
    Strand, Vibeke
    SWISS MEDICAL WEEKLY, 2022, 152 : 14S - 14S
  • [35] Induction treatment with upadacitinib is associated with high rate of clinical response in patients with refractory Inflammatory Bowel Disease
    Kitsou, V
    Ioannou, A.
    Kokkotis, G.
    Chalakatevaki, K.
    Laoudi, E.
    Leonidakis, G.
    Michopoulos, S.
    Zampeli, E.
    Bamias, G.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1750 - i1751
  • [36] IMPACT OF 12 WEEKS OF UPADACITINIB TREATMENT ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC OR BIOLOGIC DMARDS
    van Vollenhoven, R.
    Dore, R.
    Chen, K.
    Camp, H. S.
    Enejosa, J.
    Shaw, T.
    Suboticki, J. L.
    Hall, S.
    RHEUMATOLOGY, 2019, 58 : 63 - 63
  • [37] IMPACT OF 12 WEEKS OF UPADACITINIB TREATMENT ON INDIVIDUAL AND COMPOSITE DISEASE MEASURES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC OR BIOLOGIC DMARDS
    van Vollenhoven, R.
    Dore, R.
    Chen, K.
    Camp, H. S.
    Enejosa, J.
    Shaw, T.
    Suboticki, J. L.
    Hall, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 984 - 984
  • [38] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND FOLLOWING 6.9 YEARS OF TREATMENT
    Caporali, R.
    Aletaha, D.
    Sanmarti, R.
    Takeuchi, T.
    Mo, D.
    Haladyj, E.
    Zaremba-Pechmann, L.
    Taylor, P. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 617 - 618
  • [39] Treatment of patients with efatizumab after inadequate response to etanercept
    Krell, James M.
    Sobell, Jeffrey M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB189 - AB189
  • [40] Aripiprazole augmentation for treatment of patients with inadequate antidepressants response
    Pae, Chi-Un
    Patkar, Ashwin A.
    Jun, Tae-Youn
    Lee, Chul
    Masand, Prakash S.
    Paik, In-Ho
    DEPRESSION AND ANXIETY, 2007, 24 (07) : 522 - 526
12345